ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mounts
September 08, 2019Shares of the U.K. drugmaker careened to $1.44 per share in late trading Wednesday on the heels of a Bloomberg report that Mallinckrodt hired two firms to walk through bankruptcy options as a federal opioid lawsuit roundup approaches trial next month.
Pharma Sources Insight January 2025
